CIK 0001360214
- Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450567010
- Phone
- +1 615-733-4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Open-market sale Director sold 10,000 shares at $5.33 ($53,300)
- 4 Open-market sale Director sold 10,000 shares at $4.64 ($46,400)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 10,000 shares at $4.21 ($42,100)
- 4 Open-market sale Director sold 10,000 shares at $3.00 ($30,000)
- 4 Open-market sale Director sold 10,000 shares at $3.00 ($30,000)
- 4 Open-market sale Director sold 130,000 shares at $3.00 ($390,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Exercise or conversion Chief Commercial Officer acquired 30,000 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 30,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 10,000 shares at $3.05 ($30,526)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 15 · 296 filings